TY - JOUR
T1 - Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription
AU - Groussaud, Damien
AU - Khair, Mostafa
AU - Tollenaere, Armelle I.
AU - Waast, Laetitia
AU - Kuo, Mei Shiue
AU - Mangeney, Marianne
AU - Martella, Christophe
AU - Fardini, Yann
AU - Coste, Solène
AU - Souidi, Mouloud
AU - Benit, Laurence
AU - Pique, Claudine
AU - Issad, Tarik
N1 - Funding Information:
This work was supported by a grant from the Plan Cancer INSERM (CP and TI; grant number ASC13096KSA; url: https://www.eva2.inserm.fr/EVA/jsp/AppelsOffres/CANCER/). DG was a recipient of a PhD grant from the Ligue Nationale contre le Cancer (url: https://www.ligue-cancer.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH, for the C8166 and MT2 transformed T-cell lines and the anti-Tax mab, S.S Gambhir for the Rluc8 cDNA, L.K. Mahal for the OS2-O-GlcNAc biosensor cDNA and E. Harhaj for the TL-om1 T cells. We thank Camille Kostmann for some of the experiments presented as supplementary material. This work was performed within the D?partement Hospitalo-Universitaire AUToimmune and HORmonal diseaseS (AUTHORS).
Publisher Copyright:
© 2017 Groussaud et al.
PY - 2017/7
Y1 - 2017/7
N2 - The viral Tax oncoprotein plays a key role in both Human T-cell lymphotropic virus type 1 (HTLV-1)-replication and HTLV-1-associated pathologies, notably adult T-cell leukemia. Tax governs the transcription from the viral 5’LTR, enhancing thereby its own expression, via the recruitment of dimers of phosphorylated CREB to cAMP-response elements located within the U3 region (vCRE). In addition to phosphorylation, CREB is also the target of O-GlcNAcylation, another reversible post-translational modification involved in a wide range of diseases, including cancers. O-GlcNAcylation consists in the addition of O-linked-N-acetylglucosamine (O-GlcNAc) on Serine or threonine residues, a process controlled by two enzymes: O-GlcNAc transferase (OGT), which transfers O-GlcNAc on proteins, and O-GlcNAcase (OGA), which removes it. In this study, we investigated the status of O-GlcNAcylation enzymes in HTLV-1-transformed T cells. We found that OGA mRNA and protein expression levels are increased in HTLV-1-transformed T cells as compared to control T cell lines while OGT expression is unchanged. However, higher OGA production coincides with a reduction in OGA specific activity, showing that HTLV-1-transformed T cells produce high level of a less active form of OGA. Introducing Tax into HEK-293T cells or Tax-negative HTLV-1-transformed TL-om1 T cells is sufficient to inhibit OGA activity and increase total O-GlcNAcylation, without any change in OGT activity. Furthermore, Tax interacts with the OGT/OGA complex and inhibits the activity of OGT-bound OGA. Pharmacological inhibition of OGA increases CREB O-GlcNAcylation as well as HTLV-1-LTR transactivation by Tax and CREB recruitment to the LTR. Moreover, overexpression of wild-type CREB but not a CREB protein mutated on a previously described O-GlcNAcylation site enhances Tax-mediated LTR transactivation. Finally, both OGT and OGA are recruited to the LTR. These findings reveal the interplay between Tax and the O-GlcNAcylation pathway and identify new key molecular actors involved in the assembly of the Tax-dependent transactivation complex.
AB - The viral Tax oncoprotein plays a key role in both Human T-cell lymphotropic virus type 1 (HTLV-1)-replication and HTLV-1-associated pathologies, notably adult T-cell leukemia. Tax governs the transcription from the viral 5’LTR, enhancing thereby its own expression, via the recruitment of dimers of phosphorylated CREB to cAMP-response elements located within the U3 region (vCRE). In addition to phosphorylation, CREB is also the target of O-GlcNAcylation, another reversible post-translational modification involved in a wide range of diseases, including cancers. O-GlcNAcylation consists in the addition of O-linked-N-acetylglucosamine (O-GlcNAc) on Serine or threonine residues, a process controlled by two enzymes: O-GlcNAc transferase (OGT), which transfers O-GlcNAc on proteins, and O-GlcNAcase (OGA), which removes it. In this study, we investigated the status of O-GlcNAcylation enzymes in HTLV-1-transformed T cells. We found that OGA mRNA and protein expression levels are increased in HTLV-1-transformed T cells as compared to control T cell lines while OGT expression is unchanged. However, higher OGA production coincides with a reduction in OGA specific activity, showing that HTLV-1-transformed T cells produce high level of a less active form of OGA. Introducing Tax into HEK-293T cells or Tax-negative HTLV-1-transformed TL-om1 T cells is sufficient to inhibit OGA activity and increase total O-GlcNAcylation, without any change in OGT activity. Furthermore, Tax interacts with the OGT/OGA complex and inhibits the activity of OGT-bound OGA. Pharmacological inhibition of OGA increases CREB O-GlcNAcylation as well as HTLV-1-LTR transactivation by Tax and CREB recruitment to the LTR. Moreover, overexpression of wild-type CREB but not a CREB protein mutated on a previously described O-GlcNAcylation site enhances Tax-mediated LTR transactivation. Finally, both OGT and OGA are recruited to the LTR. These findings reveal the interplay between Tax and the O-GlcNAcylation pathway and identify new key molecular actors involved in the assembly of the Tax-dependent transactivation complex.
UR - http://www.scopus.com/inward/record.url?scp=85026892516&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85026892516&partnerID=8YFLogxK
U2 - 10.1371/journal.ppat.1006518
DO - 10.1371/journal.ppat.1006518
M3 - Article
C2 - 28742148
AN - SCOPUS:85026892516
SN - 1553-7366
VL - 13
JO - PLoS Pathogens
JF - PLoS Pathogens
IS - 7
M1 - e1006518
ER -